News – Page 1072 – Endpoints News

Denied: FDA rejects Agile's contraception patch for second time

8 years ago

Celgene shares sink after another PhIII lymphoma flop and J&J steps up for the late-stage BCMA race

8 years ago

The FDA just approved the 46th new drug of the year — a record high for the past decade

8 years ago

Roche lines up at the FDA's 10-yard line with $1.7B Ignyta buyout

8 years ago

J&J wows with a $350M cash deal to partner on CAR-T with Legend, a one-time unknown until its star turn at ASCO

8 years ago

Following cancer combo deal with Bristol-Myers, Taris gets $25M Series B

8 years ago

Tracon inks deal with Ambrx to develop cancer drug in China; Roche wins consecutive approvals in EU and US

8 years ago

Kymriah, Yescarta found 'cost-effective' in treating cancer, despite high price

8 years ago

Looking for an early success in PhII Alzheimer’s study, Biogen and Eisai just racked up the latest setback

8 years ago

Google backs a $60M transition round for FLX’s switch to a CCR4 strategy

8 years ago

Merck, Pfizer make a late — very late — arrival at the SGLT2 party for diabetes

8 years ago

Backed by Henri Termeer estate, Aura raises $30M for work to prevent blindness in eye cancer patients

8 years ago

In gene therapy's second big win this week, Orchard nabs $110M Series B

8 years ago

Bristol-Myers takes a stake in Taris Biomedical; Zai Lab, Five Prime strike a deal to develop tumor immunotherapy in ...

8 years ago

Another death mars AbbVie's latest batch of promising data for its star rheumatoid arthritis drug

8 years ago

Flagship adds $618M in new funds to fuel startup mission

8 years ago

A US senator calls out a little biotech for price gouging. But will it change anything?

8 years ago

After axing a top drug, Millendo bags a PhII replacement with biotech buyout

8 years ago

GAO report tracks the growth of an $89B drug R&D sector as biopharma sales soared

8 years ago

With AveXis coming up in the rear view mirror, Biogen and Ionis go back to the drawing board on SMA

8 years ago

Parker Institute-allied Tessa grabs an $80M round for its next-gen cancer cell therapies

8 years ago

FDA rolls out an early and historic OK for Spark's pioneering gene therapy -- now let's talk price

8 years ago

Roche strikes an €87.5M discovery deal with Confo; Onconova out-licenses preclinical drug to China's HanX

8 years ago

Array joins Pfizer on anti-cancer combos, the latest in a string of binimetinib combinations

8 years ago

First page Previous page 1069 1070 107110721073 1074 1075 Next page Last page